A circulating biomarker for use in monitoring metastatic breast cancer

Ended Project Grant Awarded Last action

Award ID
R44CA210817
Recipient
Awarding agency
Obligated
$1,214,005

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment -$99,823
Amendment $70,818
Amendment $0
Amendment $141,660
Amendment $0
Amendment $0
Original award $1,101,350

Quick answers

Who received award R44CA210817?

R44CA210817 was awarded to A&G Pharmaceutical, Inc. by National Cancer Institute (National Institutes of Health) on August 23, 2018.

How much is award R44CA210817 worth?

$1,214,005 has been obligated on R44CA210817.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award